These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 6488163

  • 1. Direct relationship of marrow cell growth and 1-beta-D-arabinofuranosylcytosine metabolism.
    Karp JE, Donehower RC, Dole GB, Burke PJ.
    Cancer Res; 1984 Nov; 44(11):5046-50. PubMed ID: 6488163
    [Abstract] [Full Text] [Related]

  • 2. Correlation of drug-perturbed marrow cell growth kinetics and intracellular 1-B-D-arabinofuranosylcytosine metabolism with clinical response in adult acute myelogenous leukemia.
    Karp JE, Donehower RC, Dole GB, Burke PJ.
    Blood; 1987 Apr; 69(4):1134-40. PubMed ID: 3470054
    [Abstract] [Full Text] [Related]

  • 3. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine.
    Bhalla K, Nayak R, Grant S.
    Cancer Res; 1984 Nov; 44(11):5029-37. PubMed ID: 6091869
    [Abstract] [Full Text] [Related]

  • 4. Potentiation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity by 2,3-dihydro-1H-imidazolo[1,2-b]pyrazole in the human promyelocytic leukemic cell, HL-60.
    Grant S, Bhalla K, Rauscher F, Cadman E.
    Cancer Res; 1983 Nov; 43(11):5093-100. PubMed ID: 6577943
    [Abstract] [Full Text] [Related]

  • 5. Schedule-dependent enhancement of 1-beta-D-arabinofuranosylcytosine incorporation into HL-60 DNA by deoxyguanosine.
    Ross DD, Akman SA, Joneckis CC, Yang E, Bachur NR.
    Cancer Res; 1984 Apr; 44(4):1530-5. PubMed ID: 6584206
    [Abstract] [Full Text] [Related]

  • 6. 1-beta-D-arabinofuranosylcytosine metabolism and incorporation into DNA as determinants of in vivo murine tumor cell response.
    Riva CM, Rustum YM.
    Cancer Res; 1985 Dec; 45(12 Pt 1):6244-9. PubMed ID: 2998596
    [Abstract] [Full Text] [Related]

  • 7. Effects of rhGM-CSF on intracellular ara-C pharmacology in vitro in acute myelocytic leukemia: comparability with drug-induced humoral stimulatory activity.
    Karp JE, Burke PJ, Donehower RC.
    Leukemia; 1990 Aug; 4(8):553-6. PubMed ID: 2201833
    [Abstract] [Full Text] [Related]

  • 8. Effects of 1-beta-D-arabinofuranosylcytosine on DNA replication intermediates monitored by pH-step alkaline elution.
    Ross DD, Chen SR, Cuddy DP.
    Cancer Res; 1990 May 01; 50(9):2658-66. PubMed ID: 2328491
    [Abstract] [Full Text] [Related]

  • 9. Thymidine as a kinetic and biochemical modulator of 1-beta-D-arabinofuranosylcytosine in human acute nonlymphocytic leukemia.
    Blumenreich MS, Chou TC, Andreeff M, Vale K, Clarkson BD, Young CW.
    Cancer Res; 1984 Feb 01; 44(2):825-30. PubMed ID: 6692380
    [Abstract] [Full Text] [Related]

  • 10. Role of dephosphorylation in accumulation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in human lymphoblastic cell lines with reference to their drug sensitivity.
    Abe I, Saito S, Hori K, Suzuki M, Sato H.
    Cancer Res; 1982 Jul 01; 42(7):2846-51. PubMed ID: 7083175
    [Abstract] [Full Text] [Related]

  • 11. Enhancement of drug cytotoxicity by recruitment of leukemic myeloblasts with humoral stimulation.
    Karp JE, Burke PJ.
    Cancer Res; 1976 Oct 01; 36(10):3600-3. PubMed ID: 1066183
    [Abstract] [Full Text] [Related]

  • 12. Modulation of the metabolism and pharmacokinetics of 1-beta-D-arabinofuranosylcytosine by 1-beta-D-arabinofuranosyluracil in leukemic mice.
    Chandrasekaran B, Capizzi RL, Kute TE, Morgan T, Dimling J.
    Cancer Res; 1989 Jun 15; 49(12):3259-66. PubMed ID: 2720678
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Potentiation of cytotoxicity of 1-beta-D-arabinofuranosylcytosine for K562 human leukemic cells by cadeguomycin.
    Suzuki H, Kim SH, Tanara M, Okazaki K, Okabe T, Wu RT, Tanaka N.
    Cancer Res; 1987 Feb 01; 47(3):713-7. PubMed ID: 3467840
    [Abstract] [Full Text] [Related]

  • 15. Quantitation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in the leukemic cells from bone marrow and peripheral blood of patients receiving 1-beta-D-arabinofuranosylcytosine therapy.
    Plunkett W, Hug V, Keating MJ, Chubb S.
    Cancer Res; 1980 Mar 01; 40(3):588-91. PubMed ID: 6937239
    [Abstract] [Full Text] [Related]

  • 16. Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: a model of leukemia in Down syndrome.
    Taub JW, Huang X, Ge Y, Dutcher JA, Stout ML, Mohammad RM, Ravindranath Y, Matherly LH.
    Cancer Res; 2000 Nov 15; 60(22):6421-6. PubMed ID: 11103808
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Metabolism, incorporation into DNA, and interactions with 1-beta-D-arabinofuranosylcytosine of 5-hydroxymethyl-2'-deoxyuridine in human promyelocytic leukemia cells (HL-60).
    Vilpo JA, Vilpo LM.
    Cancer Res; 1988 Jun 01; 48(11):3117-22. PubMed ID: 3163271
    [Abstract] [Full Text] [Related]

  • 19. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
    Grant S, Freemerman AJ, Birrer MJ, Martin HA, Turner AJ, Szabo E, Chelliah J, Jarvis WD.
    Cell Growth Differ; 1996 May 01; 7(5):603-13. PubMed ID: 8732670
    [Abstract] [Full Text] [Related]

  • 20. Incorporation of 1-beta-D-arabinofuranosylcytosine into DNA from herpes simplex virus resistant to 9-beta-D-arabinofuranosyladenine.
    Kufe D, Herrick D, Crumpacker C, Schnipper L.
    Cancer Res; 1984 Jan 01; 44(1):69-73. PubMed ID: 6317173
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.